Screening suspect pharmaceuticals for illicit designer benzodiazepines using raman, SERS, and FT-IR prior to comprehensive analysis using LC-MS

Benzodiazepine prescribing patterns and deaths from drug overdose among US veterans receiving opioid analgesics: case-cohort study

Tae Woo Park, R Saitz, Dara Ganoczy et al. · BMJ · 2015 · 564 citations · Full text

Increasing Benzodiazepine Prescriptions and Overdose Mortality in the United States, 1996–2013

Marcus A. Bachhuber, Sean Hennessy, Chinazo O. Cunningham et al. · American Journal of Public Health · 2016 · 515 citations · Full text

Trends in Nonfatal and Fatal Overdoses Involving Benzodiazepines — 38 States and the District of Columbia, 2019–2020

Stephen V. Liu, Julie O’Donnell, R. Matt Gladden et al. · MMWR Morbidity and Mortality Weekly Report · 2021 · 97 citations · Full text

Detectability of designer benzodiazepines in CEDIA, EMIT II Plus, HEIA, and KIMS II immunochemical screening assays

Madeleine Pettersson Bergstrand, Anders Helander, Therése Hansson et al. · Drug Testing and Analysis · 2016 · 89 citations

Characterization of the designer benzodiazepine diclazepam and preliminary data on its metabolism and pharmacokinetics

Bjoern Moosmann, Philippe Bisel, Volker Auwärter · Drug Testing and Analysis · 2014 · 85 citations